Opinion|Videos|June 19, 2024
Getting the Most From Your CLL Care Team
Josie Montegaard, MSN, AGPCNP-BC, and Yuliya Linhares, MD, conclude their discussion with advice for patients with CLL on managing their diagnosis and treatment.
Advertisement
Episodes in this series
Video content above is prompted by the following question(s):
- Do you have any advice for patients and their caregivers about how to work with their health care team to ensure best outcomes?
- Why is it important for patients with chronic lymphocytic leukemia (CLL) to have a support network in place?
- How and when should patients reach out to their health care team about treatment adverse effects or any changes in how they’re feeling?
- Do you have any additional advice or key takeaways for patients as they manage their CLL diagnosis and treatment?
Advertisement
Related to this article
Immunotherapy is a mainstay of lung cancer treatment, and its side effects are different from chemotherapy's. Here are five to know, what they feel like and how care teams treat them.
Brad Dugai and Russ Reed discuss symptom relief, skin-related side effects and challenges accessing Rasonque, a treatment for pancreatic cancer.
Patients with PD-L1-negative non-small cell lung cancer experienced longer progression-free survival with sac-TMT plus Keytruda compared with chemotherapy plus Keytruda in a phase 3 trial.
For National Hospice and Palliative Care Month, answers to common questions about how palliative care differs from hospice, who qualifies, what Medicare covers and how to find a program.
A nurse practitioner discusses how an app provides information on cancer treatments, potential side effects and preparing for medical appointments.
A breast cancer survivor shares how cancer turned gratitude into an everyday practice and why it's OK when the holidays bring both joy and grief this year.
Final KEYNOTE-564 data show Keytruda after kidney cancer surgery lowered the risk of death by 30%. Dr. Toni Choueiri explains what it means for patients.
HealthCare.gov open enrollment runs Nov. 1, 2026, to Jan. 15, 2027, and the 2027 out-of-pocket ceiling rises to $12,000. Here's what people with cancer should check before picking a plan.
Advertisement
Advertisement
Trending on CURE
1
Why a Patient With Pancreatic Cancer Moved From Chemotherapy to Rasonque
2
Sac-TMT Plus Keytruda Improves Outcomes in PD-L1-Negative Lung Cancer
3
Keytruda After Kidney Cancer Surgery Lowers Risk of Death by 30%
4
After Breast Cancer, Thanksgiving Is No Longer Just One Day
5